{"cursor":"3060","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed verifiedrevid = 470611959\n\n\n| type = mab mab_type = mab source = o target = CD20\n\n\n| tradename = Bexxar Drugs.com = MedlinePlus = a609013 pregnancy_AU =  pregnancy_US = \n| legal_AU =  legal_UK =  legal_US = \n\n\n| ChemSpiderID_Ref = ChemSpiderID = NA CAS_number_Ref = CAS_number = 192391-48-3\n| ATC_prefix = V10 ATC_suffix = XA53 ATC_supplemental = (sequential regimen with\n| 131 I form) DrugBank_Ref = DrugBank = DB00081 UNII_Ref = UNII =\n| 0343IGH41U KEGG_Ref = KEGG = D08622 ChEMBL_Ref = ChEMBL = 1201604\n\n\n| C=6416 | H=9874 | N=1688 | O=1987 | S=44 molecular_weight = 143859.7 g/mol\n}} 'Tositumomab' is a drug for the treatment of follicular lymphoma. It is an\nIgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cells.\n\nTositumomab is applied in a sequential infusion followed by 'iodine\n( 131 I) tositumomab', which is the same antibody covalently bound to\nthe radionuclide iodine-131\n( 131 I). [http://us.gsk.com/products/assets/us_bexxar.pdf Bexxar\nPrescribing Information] 131 I emits both beta and gamma\nradiation and decays with a half-life of 8 days.\n\nClinical trials have established the efficacy of the tositumomab/iodine\n( 131 I) tositumomab regimen in patients with relapsed or\nchemotherapy/rituxan refractory follicular lymphoma.\n\nThis drug combination is manufactured by Corixa (now GlaxoSmithKline). It sells\nin the U.S. under the trade name 'Bexxar'.\n\nBexxar was developed by Dr. Mark Kaminski and Dr. Richard Wahl.\n\nThere is some evidence that it may cause a smaller decrease in platelet counts\nthan ibritumomab tiuxetan does.\n","linknr":426,"url":"Tositumomab","recorded":1364151366,"links":["/w/index.php?title=Tositumomab&action=edit","/w/index.php?title=Tositumomab&action=edit","//en.wikipedia.org/apple-touch-icon.png","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-head","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Monoclonal_antibody#Production","/wiki/Mouse","/wiki/Antigen","/wiki/CD20","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/tositumomab.html","/wiki/MedlinePlus","http://www.nlm.nih.gov/medlineplus/druginfo/meds/a609013.html","/wiki/Pregnancy_category","/wiki/Regulation_of_therapeutic_goods","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=192391-48-3&rn=1","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_V10","http://www.whocc.no/atc_ddd_index/?code=V10XA53","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00081","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=0343IGH41U","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D08622","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201604","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470611959&page2=Tositumomab","/wiki/Follicular_lymphoma","/wiki/IgG","/wiki/CD20","/wiki/Monoclonal_antibody","/wiki/Radionuclide","/wiki/Iodine-131","#cite_note-1","/wiki/Beta_radiation","/wiki/Gamma_radiation","/wiki/Half-life","/wiki/Chemotherapy","/wiki/Rituxan","/wiki/Refractory","/wiki/Corixa","/wiki/GlaxoSmithKline","/wiki/Platelet","/wiki/Ibritumomab_tiuxetan","#cite_note-pmid17942813-2","/w/index.php?title=Tositumomab&action=edit&section=1","#cite_ref-1","http://us.gsk.com/products/assets/us_bexxar.pdf","#cite_ref-pmid17942813_2-0","http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=17942813","/wiki/J._Nucl._Med.","/wiki/Digital_object_identifier","http://dx.doi.org/10.2967%2Fjnumed.107.043489","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17942813","http://www.med.umich.edu/medschool/faculty/facultyawards/2005/kaminski.htm","/w/index.php?title=Tositumomab&action=edit&section=2","http://www.cancer.gov/dictionary?CdrID=367411","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template_talk:Extracellular_chemotherapeutic_agents","//en.wikipedia.org/w/index.php?title=Template:Extracellular_chemotherapeutic_agents&action=edit","/wiki/Targeted_therapy","/wiki/Chemotherapy_(oncology)","/wiki/Antineoplastic","/wiki/ATC_code_L01","/wiki/Cancer_immunotherapy","/wiki/Monoclonal_antibody_therapy","/wiki/Receptor_tyrosine_kinase","/wiki/ErbB","/wiki/Epidermal_growth_factor_receptor","/wiki/Cetuximab","/wiki/Panitumumab","/wiki/HER2/neu","/wiki/Trastuzumab","/wiki/Trastuzumab_emtansine","/wiki/EpCAM","/wiki/Catumaxomab","/wiki/Edrecolomab","/wiki/Vascular_endothelial_growth_factor_A","/wiki/Bevacizumab","/wiki/Leukemia","/wiki/Lymphoma","/wiki/Lymphatic_system","/wiki/CD20","/wiki/Ibritumomab_tiuxetan","/wiki/Ofatumumab","/wiki/Rituximab","/wiki/CD30","/wiki/Brentuximab_vedotin","/wiki/CD52","/wiki/Alemtuzumab","/wiki/Myeloid","/wiki/CD33","/wiki/Gemtuzumab_ozogamicin","/wiki/Tyrosine-kinase_inhibitor","/wiki/Receptor_tyrosine_kinase","/wiki/ErbB","/wiki/Epidermal_growth_factor_receptor","/wiki/Erlotinib","/wiki/Gefitinib","/wiki/Vandetanib","/wiki/HER2/neu","/wiki/Afatinib","/wiki/Lapatinib","/wiki/Neratinib","/wiki/RTK_class_III","/wiki/CD117","/wiki/Platelet-derived_growth_factor_receptor","/wiki/Axitinib","/wiki/Masitinib","/wiki/Pazopanib","/wiki/Sunitinib","/wiki/Sorafenib","/wiki/Toceranib","/wiki/CD135","/wiki/Lestaurtinib","/wiki/VEGF_receptors","/wiki/Axitinib","/wiki/Cediranib","/wiki/Pazopanib","/wiki/Regorafenib","/wiki/Semaxanib","/wiki/Sorafenib","/wiki/Sunitinib","/wiki/Toceranib","/wiki/Vandetanib","/wiki/Non-receptor_tyrosine_kinase","/wiki/Bcr-abl_fusion_protein","/wiki/Imatinib","/wiki/Dasatinib","/wiki/Nilotinib","/wiki/Ponatinib","/wiki/Src_(gene)","/wiki/Bosutinib","/wiki/Janus_kinase","/wiki/Lestaurtinib","/wiki/Ruxolitinib","/wiki/EML4","/wiki/Anaplastic_lymphoma_kinase","/wiki/Crizotinib","/wiki/Vandetanib","/wiki/Cabozantinib","/wiki/Fusion_protein","/wiki/Vascular_endothelial_growth_factor","/wiki/Aflibercept","/wiki/Proapoptotic","/wiki/ANXA2","/wiki/Prohibitin","/wiki/Adipotide","/wiki/Exotoxin","/wiki/Interleukin_2","/wiki/Denileukin_diftitox","/wiki/MTOR_inhibitor","/wiki/Everolimus","/wiki/Temsirolimus","/wiki/Template:Medicine_navs","/wiki/Neoplasm","/wiki/Template:Tumor_suppressor_genes_and_oncogenes","/wiki/Template:Tumor_markers","/wiki/Template:Tumors","/wiki/Template:Eponymous_medical_signs_for_oncology","/wiki/Template:Paraneoplastic_syndromes","/wiki/ATC_code_L","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment","/wiki/Template:Monoclonals_for_tumors","/wiki/Template_talk:Monoclonals_for_tumors","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_tumors&action=edit","/wiki/Monoclonal_antibodies","/wiki/Tumor","/wiki/Adecatumumab","/wiki/Cixutumumab","/wiki/Conatumumab","/wiki/Daratumumab","/wiki/Drozitumab","/wiki/Duligotumab","/wiki/Dusigitumab","/wiki/Figitumumab","/wiki/Ganitumab","/wiki/Glembatumumab_vedotin","/wiki/Intetumumab","/wiki/Iratumumab","/wiki/Lexatumumab","/wiki/Lucatumumab","/wiki/Mapatumumab","/wiki/Narnatumab","/wiki/Necitumumab","/wiki/Ofatumumab","/wiki/Olaratumab","/wiki/Panitumumab","/wiki/Patritumab","/wiki/Pritumumab","/wiki/Radretumab","/wiki/Rilotumumab","/wiki/Robatumumab","/wiki/Teprotumumab","/wiki/Tovetumab","/wiki/Vantictumab","/wiki/Technetium_(99mTc)_votumumab","/wiki/Zalutumumab","/wiki/Melanoma","/wiki/Flanvotumab","/wiki/Indium_(111In)_altumomab_pentetate","/wiki/Anatumomab_mafenatox","/wiki/Technetium_(99mTc)_arcitumomab","/wiki/Bectumomab","/wiki/Blinatumomab","/wiki/Iodine_(125I)_CC49","/wiki/Detumomab","/wiki/Ibritumomab_tiuxetan","/wiki/Minretumomab","/wiki/Mitumomab","/wiki/Moxetumomab_pasudotox","/wiki/Naptumomab_estafenatox","/wiki/Technetium_(99mTc)_nofetumomab_merpentan","/wiki/Pemtumomab","/wiki/Technetium_(99mTc)_pintumomab","/wiki/Racotumomab","/wiki/Indium_(111In)_satumomab_pendetide","/wiki/Solitomab","/wiki/Taplitumomab_paptox","/wiki/Tenatumomab","/wiki/3F8","/wiki/Ovarian_tumor","/wiki/Abagovomab","/wiki/Indium_(111In)_igovomab","/wiki/Oregovomab","/wiki/Indium_(111In)_capromab_pendetide","/wiki/Edrecolomab","/wiki/Nacolomab_tafenatox","/wiki/Chimeric_antibody","/wiki/Amatuximab","/wiki/Bavituximab","/wiki/Brentuximab_vedotin","/wiki/Cetuximab","/wiki/Ensituximab","/wiki/Futuximab","/wiki/Girentuximab","/wiki/Indatuximab_ravtansine","/wiki/Margetuximab","/wiki/Rituximab","/wiki/Siltuximab","/wiki/Ublituximab","/wiki/Melanoma","/wiki/Ecromeximab","/wiki/Humanized_antibody","/wiki/Afutuzumab","/wiki/Alemtuzumab","/wiki/Bevacizumab","/wiki/Bivatuzumab_mertansine","/wiki/Cantuzumab_mertansine","/wiki/Cantuzumab_ravtansine","/wiki/Citatuzumab_bogatox","/wiki/Yttrium_(90Y)_clivatuzumab_tetraxetan","/wiki/Dacetuzumab","/wiki/Dalotuzumab","/wiki/Elotuzumab","/wiki/Etaracizumab","/wiki/Farletuzumab","/wiki/Ficlatuzumab","/wiki/Gemtuzumab_ozogamicin","/wiki/Imgatuzumab","/wiki/Inotuzumab_ozogamicin","/wiki/Labetuzumab","/wiki/Lintuzumab","/wiki/Lorvotuzumab_mertansine","/wiki/Matuzumab","/wiki/Milatuzumab","/wiki/Nimotuzumab","/wiki/Ocaratuzumab","/wiki/Onartuzumab","/wiki/Oportuzumab_monatox","/wiki/Parsatuzumab","/wiki/Pertuzumab","/wiki/Sibrotuzumab","/wiki/Simtuzumab","/wiki/Yttrium_(90Y)_tacatuzumab_tetraxetan","/wiki/Tigatuzumab","/wiki/Trastuzumab","/wiki/Tucotuzumab_celmoleukin","/wiki/Veltuzumab","/wiki/Vorsetuzumab_mafodotin","/wiki/Trifunctional_antibody","/wiki/Catumaxomab","/wiki/Ertumaxomab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Radiopharmaceuticals","/wiki/Template_talk:Radiopharmaceuticals","//en.wikipedia.org/w/index.php?title=Template:Radiopharmaceuticals&action=edit","/wiki/Radiopharmacology","/wiki/ATC_code_V10","/wiki/Palliation","/wiki/Samarium-153","/wiki/Samarium_(153Sm)_lexidronam","/wiki/Strontium-89","/wiki/Adrenergic","/wiki/Iodine-131","/wiki/Iobenguane","/wiki/CD20","/wiki/Monoclonal_antibody","/wiki/Yttrium-90","/wiki/Ibritumomab_tiuxetan","/wiki/Iodine-131","/wiki/Radionuclide","/wiki/Beta_particle","/wiki/Electron","/wiki/Samarium-153","/wiki/Yttrium-90","/wiki/Phosphorus-32","/wiki/Iodine-131","/wiki/Strontium-89","/wiki/Dysprosium-165","/wiki/Erbium-169","/wiki/Rhenium-186","/wiki/Gold-198","/wiki/File:Cisplatin-3D-vdW.png","//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Cisplatin-3D-vdW.png/40px-Cisplatin-3D-vdW.png","/wiki/Antineoplastic","/wiki/Immunomodulator","/wiki/Pharmaceutical_drug","/wiki/Wikipedia:Stub","//en.wikipedia.org/w/index.php?title=Tositumomab&action=edit","/wiki/Template:Antineoplastic-drug-stub","/wiki/Template_talk:Antineoplastic-drug-stub","//en.wikipedia.org/w/index.php?title=Template:Antineoplastic-drug-stub&action=edit","/wiki/File:Inmunoglobulina.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Inmunoglobulina.png/37px-Inmunoglobulina.png","/wiki/Monoclonal_antibody","/wiki/Wikipedia:Stub","//en.wikipedia.org/w/index.php?title=Tositumomab&action=edit","/wiki/Template:Monoclonal-antibody-stub","/wiki/Template_talk:Monoclonal-antibody-stub","//en.wikipedia.org/w/index.php?title=Template:Monoclonal-antibody-stub&action=edit","http://en.wikipedia.org/w/index.php?title=Tositumomab&oldid=544516240","/wiki/Help:Categories","/wiki/Category:Monoclonal_antibodies","/wiki/Category:Antineoplastic_and_immunomodulating_drug_stubs","/wiki/Category:Monoclonal_antibody_stubs","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/w/index.php?title=Special:UserLogin&returnto=Tositumomab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Tositumomab","/wiki/Tositumomab","/wiki/Talk:Tositumomab","#","/wiki/Tositumomab","/w/index.php?title=Tositumomab&action=edit","/w/index.php?title=Tositumomab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.21wmf11/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Tositumomab","/wiki/Special:RecentChangesLinked/Tositumomab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Tositumomab&oldid=544516240","/w/index.php?title=Tositumomab&action=info","/w/index.php?title=Special:Cite&page=Tositumomab&id=544516240","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Tositumomab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Tositumomab&oldid=544516240&writer=rl","/w/index.php?title=Tositumomab&printable=yes","//it.wikipedia.org/wiki/Tositumomab","//www.wikidata.org/wiki/Special:ItemByTitle/enwiki/Tositumomab","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//www.wikimediafoundation.org/","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","http://en.m.wikipedia.org/wiki/Tositumomab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=skins.vector&only=scripts&skin=vector&*","/w/index.php?title=MediaWiki:Gadget-ReferenceTooltips.js&action=raw&ctype=text/javascript&508635914","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://us.gsk.com/products/assets/us_bexxar.pdf"],"categories":["Monoclonal antibodies"],"headings":["References","External links"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Cisplatin-3D-vdW.png/40px-Cisplatin-3D-vdW.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Inmunoglobulina.png/37px-Inmunoglobulina.png","//bits.wikimedia.org/static-1.21wmf11/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["CD20","Follicular_lymphoma","IgG","CD20","Monoclonal_antibody","Radionuclide","Iodine-131","Beta_radiation","Gamma_radiation","Half-life","Chemotherapy","Rituxan","Refractory","Corixa","GlaxoSmithKline","Platelet","Ibritumomab_tiuxetan"]}